Cite
HARVARD Citation
Yang, C. et al. (2021). Association of Renal and Cardiovascular Safety With DPP‐4 Inhibitors vs. Sulfonylureas in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease. Clinical pharmacology & therapeutics. 110 (2), pp. 464-472. [Online].